Baixar PDF

Outros usuários também visualizaram estes artigos

Results of the daratumumab monotherapy early access treatment protocol in patients from Brazil with relapsed or refractory multiple myeloma Edvan de Queiroz Crusoé; Flávia Cristina Fernandes Pimenta; Angelo Maiolino; Nelson Siqueira de Castro; Huiling Pei; Damila Trufelli; Mariana Fernandez; Luciana Barreto Herriot;
Hematol Transfus Cell Ther. 2021;43:417-23
Cyclophosphamide-glucocorticoids versus lenalidomide-dexamethasone as treatment for multiple myeloma at first relapse after autologous stem cell transplantation ¿ a retrospective analysis Russell Sterrett; Amarilis Figueiredo; Ranjeeta Mallick; Natasha Kekre; Harold Atkins; Arleigh McCurdy;
Hematol Transfus Cell Ther. 2021;43:437-42
Treatment of relapsed, refractory multiple myeloma: focus on new drugs Angelo Maiolino;
Hematol Transfus Cell Ther. 2020;42 Supl 1:2-3